{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T08:35:17Z","timestamp":1770453317563,"version":"3.49.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T00:00:00Z","timestamp":1768003200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:00:00Z","timestamp":1770336000000},"content-version":"vor","delay-in-days":27,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"DOI":"10.1186\/s12884-025-08606-9","type":"journal-article","created":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T02:05:29Z","timestamp":1768010729000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical features of non-criteria obstetric antiphospholipid syndrome: a retrospective cohort study on antibody-based risk classification and pregnancy outcomes"],"prefix":"10.1186","volume":"26","author":[{"given":"Wenjie","family":"Fu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huaping","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,10]]},"reference":[{"issue":"Suppl 1","key":"8606_CR1","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.1016\/j.medcli.2024.05.001","volume":"163","author":"A Soto-Peleteiro","year":"2024","unstructured":"Soto-Peleteiro A, Gonzalez-Echavarri C, Ruiz-Irastorza G. Obstetric antiphospholipid syndrome. Med Clin (Barc). 2024;163(Suppl 1):S14\u201321.","journal-title":"Med Clin (Barc)"},{"issue":"3","key":"8606_CR2","doi-asserted-by":"publisher","first-page":"e13931","DOI":"10.1111\/aji.13931","volume":"92","author":"H Liu","year":"2024","unstructured":"Liu H, Han J, Gao R, Hu Z, Tang Y, Qin L. Clinical features between primary obstetric antiphospholipid syndrome and Non-Criteria obstetric antiphospholipid syndrome and risk factors of adverse pregnancy outcomes: A retrospective study of 1006 cases. Am J Reprod Immunol. 2024;92(3):e13931.","journal-title":"Am J Reprod Immunol"},{"key":"8606_CR3","doi-asserted-by":"crossref","unstructured":"Be\u00e7a S, Borrell M, Cervera R, et al. Non-Criteria obstetric antiphospholipid syndrome: myth or reality. J Clin Med. 2025;14(4):1299.","DOI":"10.3390\/jcm14041299"},{"key":"8606_CR4","doi-asserted-by":"publisher","first-page":"104389","DOI":"10.1016\/j.jri.2024.104389","volume":"166","author":"X Qi","year":"2024","unstructured":"Qi X, Liu P, Zhou Y, et al. Transcriptomics analysis of differential gene expression and immune and inflammatory response mechanisms in patients with typical and non-criteria obstetric antiphospholipid syndrome (OAPS and NC-OAPS). J Reprod Immunol. 2024;166:104389.","journal-title":"J Reprod Immunol"},{"issue":"9","key":"8606_CR5","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1182\/blood.2023020727","volume":"143","author":"DW Branch","year":"2024","unstructured":"Branch DW, Lim MY. How I diagnose and treat antiphospholipid syndrome in pregnancy. Blood. 2024;143(9):757\u201368.","journal-title":"Blood"},{"issue":"2","key":"8606_CR6","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.jtha.2024.10.022","volume":"23","author":"K Devreese","year":"2025","unstructured":"Devreese K, Bertolaccini ML, Branch DW, et al. An update on laboratory detection and interpretation of antiphospholipid antibodies for diagnosis of antiphospholipid syndrome: guidance from the ISTH-SSC subcommittee on lupus Anticoagulant\/Antiphospholipid antibodies. J Thromb Haemost. 2025;23(2):731\u201344.","journal-title":"J Thromb Haemost"},{"issue":"1","key":"8606_CR7","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1186\/s12884-025-07471-w","volume":"25","author":"VR Murvai","year":"2025","unstructured":"Murvai VR, Gali\u0219 R, Panaitescu A, et al. Antiphospholipid syndrome in pregnancy: a comprehensive literature review. BMC Pregnancy Childbirth. 2025;25(1):337.","journal-title":"BMC Pregnancy Childbirth"},{"issue":"5","key":"8606_CR8","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1136\/ard-2023-224930","volume":"83","author":"C Lu","year":"2024","unstructured":"Lu C, Gao R, Qing P, et al. Single-cell transcriptome analyses reveal disturbed decidual homoeostasis in obstetric antiphospholipid syndrome. Ann Rheum Dis. 2024;83(5):624\u201337.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"8606_CR9","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s10557-023-07496-3","volume":"39","author":"L Depietri","year":"2025","unstructured":"Depietri L, Veropalumbo MR, Leone MC, Ghirarduzzi A. Antiphospholipid syndrome: state of the Art of clinical management. Cardiovasc Drugs Ther. 2025;39(2):385\u2013404.","journal-title":"Cardiovasc Drugs Ther"},{"issue":"8","key":"8606_CR10","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.1016\/j.jtha.2024.03.027","volume":"22","author":"JE Manning","year":"2024","unstructured":"Manning JE, Arachchillage DJ. Dilemmas in the diagnosis and management of antiphospholipid syndrome. J Thromb Haemost. 2024;22(8):2156\u201370.","journal-title":"J Thromb Haemost"},{"issue":"2","key":"8606_CR11","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.medcli.2023.03.011","volume":"161","author":"JA Gir\u00f3n-Ortega","year":"2023","unstructured":"Gir\u00f3n-Ortega JA, Gir\u00f3n-Gonz\u00e1lez JA. [Direct-acting oral anticoagulants in antiphospholipid syndrome: A systematic review]. Med Clin (Barc). 2023;161(2):65\u201377.","journal-title":"Med Clin (Barc)"},{"issue":"5","key":"8606_CR12","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1097\/AOG.0000000000005498","volume":"143","author":"V de Assis","year":"2024","unstructured":"de Assis V, Giugni CS, Ros ST. Evaluation of recurrent pregnancy loss. Obstet Gynecol. 2024;143(5):645\u201359.","journal-title":"Obstet Gynecol"},{"issue":"1","key":"8606_CR13","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1182\/hematology.2023000493","volume":"2023","author":"A Hubben","year":"2023","unstructured":"Hubben A, McCrae KR. How to diagnose and manage antiphospholipid syndrome. Hematol Am Soc Hematol Educ Program. 2023;2023(1):606\u201313.","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"3","key":"8606_CR14","first-page":"513","volume":"55","author":"R Gao","year":"2024","unstructured":"Gao R, Qin L. [Obstetric antiphospholipid syndrome: insights on the Diagnosis, Treatment, and hot Issues]. Sichuan Da Xue Xue Bao Yi Xue Ban. 2024;55(3):513\u201320.","journal-title":"Sichuan Da Xue Xue Bao Yi Xue Ban"},{"key":"8606_CR15","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.placenta.2023.06.013","volume":"139","author":"AS Castellanos Gutierrez","year":"2023","unstructured":"Castellanos Gutierrez AS, Figueras F, Espinosa G, et al. Correlation of placental lesions in patients with systemic lupus erythematosus, antiphospholipid syndrome and non-criteria obstetric antiphospholipid syndrome and adverse perinatal outcomes. Placenta. 2023;139:92\u20138.","journal-title":"Placenta"},{"issue":"Suppl 1","key":"8606_CR16","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1016\/j.medcli.2024.06.002","volume":"163","author":"S Sciascia","year":"2024","unstructured":"Sciascia S, Montaruli B, Infantino M. Antiphospholipid antibody testing. Med Clin (Barc). 2024;163(Suppl 1):S4\u20139.","journal-title":"Med Clin (Barc)"},{"issue":"SI","key":"8606_CR17","doi-asserted-by":"publisher","first-page":"SI86","DOI":"10.1093\/rheumatology\/kead537","volume":"63","author":"L Andreoli","year":"2024","unstructured":"Andreoli L, Regola F, Caproli A, et al. Pregnancy in antiphospholipid syndrome: what should a rheumatologist know. Rheumatology (Oxford). 2024;63(SI):SI86\u201395.","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"8606_CR18","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/s41584-024-01110-y","volume":"20","author":"JS Knight","year":"2024","unstructured":"Knight JS, Erkan D. Rethinking antiphospholipid syndrome to guide future management and research. Nat Rev Rheumatol. 2024;20(6):377\u201388.","journal-title":"Nat Rev Rheumatol"},{"issue":"10","key":"8606_CR19","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1136\/ard-2023-224609","volume":"82","author":"M Barbhaiya","year":"2023","unstructured":"Barbhaiya M, Zuily S, Naden R, et al. 2023 ACR\/EULAR antiphospholipid syndrome classification criteria. Ann Rheum Dis. 2023;82(10):1258\u201370.","journal-title":"Ann Rheum Dis"},{"key":"8606_CR20","doi-asserted-by":"crossref","unstructured":"Hansen RS, Larsen JB, Vinholt PJ, Voss A, Abildgaard A. Antiphospholipid antibodies and antiphospholipid syndrome. Ugeskr Laeger. 2024;186(21):V11230715.","DOI":"10.61409\/V11230715"},{"issue":"8","key":"8606_CR21","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1111\/jth.13379","volume":"14","author":"H de Kelchtermans","year":"2016","unstructured":"Kelchtermans H, Pelkmans L, de Laat B, Devreese KM. IgG\/IgM antiphospholipid antibodies present in the classification criteria for the antiphospholipid syndrome: a critical review of their association with thrombosis. J Thromb Haemostasis: JTH. 2016;14(8):1530\u201348.","journal-title":"J Thromb Haemostasis: JTH"},{"issue":"5","key":"8606_CR22","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/j.thromres.2015.08.021","volume":"136","author":"T Iwaniec","year":"2015","unstructured":"Iwaniec T, Kaczor MP, Celi\u0144ska-L\u00f6wenhoff M. Pola\u0144ski S&M, J. Clinical utility of automated chemiluminescent antiphospholipid antibody assay. Thromb. 2015;136(5):1033\u20139.","journal-title":"Thromb"},{"key":"8606_CR23","doi-asserted-by":"publisher","first-page":"1122127","DOI":"10.3389\/fimmu.2023.1122127","volume":"14","author":"X Peng","year":"2023","unstructured":"Peng X, Tan X, Xing A. An advanced Understanding of the heterogeneous clinical features of non-criteria obstetric antiphospholipid syndrome: two case reports and a literature review. Front Immunol. 2023;14:1122127.","journal-title":"Front Immunol"},{"issue":"12","key":"8606_CR24","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1177\/09612033211038054","volume":"30","author":"C Baleeiro","year":"2021","unstructured":"Baleeiro C, Duran CS, Signorelli F, Balbi GG, Bonf\u00e1 E, Andrade DC. Distinct features of youth-onset primary antiphospholipid syndrome. Lupus. 2021;30(12):1888\u201395.","journal-title":"Lupus"},{"issue":"216","key":"8606_CR25","first-page":"133","volume":"57","author":"B Vaidya","year":"2019","unstructured":"Vaidya B, Nakarmi S, Joshi R, Baral R. A simplified Understanding of the black swan: Anti-phospholipid antibody syndrome. JNMA J Nepal Med Assoc. 2019;57(216):133\u201345.","journal-title":"JNMA J Nepal Med Assoc"},{"issue":"1","key":"8606_CR26","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s13317-020-00131-3","volume":"11","author":"I Volkov","year":"2020","unstructured":"Volkov I, Seguro L, Leon EP, et al. Profiles of criteria and non-criteria anti-phospholipid autoantibodies are associated with clinical phenotypes of the antiphospholipid syndrome. Auto Immun Highlights. 2020;11(1):8.","journal-title":"Auto Immun Highlights"},{"issue":"2","key":"8606_CR27","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1080\/03009742.2022.2082114","volume":"52","author":"G Pires da Rosa","year":"2023","unstructured":"Pires da Rosa G, Ferreira E, Sousa-Pinto B, Bettencourt P, Espinosa G, Cervera R. Patients with laboratory criteria of anti-phospholipid syndrome and \u2018non-criteria\u2019 manifestations: a multicenter cohort. Scand J Rheumatol. 2023;52(2):190\u20135.","journal-title":"Scand J Rheumatol"},{"key":"8606_CR28","doi-asserted-by":"crossref","unstructured":"Devreese K, Wahl D. Challenges of laboratory testing in patients suspected of antiphospholipid syndrome: practical implications for clinicians. Pol Arch Intern Med. 2024;134(11):16849.","DOI":"10.20452\/pamw.16849"},{"issue":"4","key":"8606_CR29","doi-asserted-by":"publisher","first-page":"e13258","DOI":"10.1111\/aji.13258","volume":"85","author":"A Beltagy","year":"2021","unstructured":"Beltagy A, Trespidi L, Gerosa M, Ossola MW, Meroni PL, Chighizola CB. Anti-phospholipid antibodies and reproductive failures. Am J Reprod Immunol. 2021;85(4):e13258.","journal-title":"Am J Reprod Immunol"},{"key":"8606_CR30","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.placenta.2024.06.019","volume":"154","author":"C Gros","year":"2024","unstructured":"Gros C, Mageau A, Barral T, et al. Criteria and non-criteria antiphospholipid autoantibodies screening in patients with late pregnancy morbidity: A cross-sectional study. Placenta. 2024;154:122\u20138.","journal-title":"Placenta"},{"issue":"2","key":"8606_CR31","doi-asserted-by":"publisher","first-page":"163","DOI":"10.46497\/ArchRheumatol.2023.41875","volume":"38","author":"A Bahar Kele\u015fo\u011flu Din\u00e7er","year":"2023","unstructured":"Bahar Kele\u015fo\u011flu Din\u00e7er A, Erkan D. The ABCs of antiphospholipid syndrome. Arch Rheumatol. 2023;38(2):163\u201373.","journal-title":"Arch Rheumatol"},{"issue":"10","key":"8606_CR32","doi-asserted-by":"publisher","first-page":"102901","DOI":"10.1016\/j.autrev.2021.102901","volume":"20","author":"IJ Walter","year":"2021","unstructured":"Walter IJ, Klein Haneveld MJ, Lely AT, Bloemenkamp K, Limper M, Kooiman J. Pregnancy outcome predictors in antiphospholipid syndrome: A systematic review and meta-analysis. Autoimmun Rev. 2021;20(10):102901.","journal-title":"Autoimmun Rev"},{"issue":"3","key":"8606_CR33","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1093\/rheumatology\/keaa499","volume":"60","author":"A Spinillo","year":"2021","unstructured":"Spinillo A, Bellingeri C, Cavagnoli C, et al. Maternal and foetal placental vascular malperfusion in pregnancies with anti-phospholipid antibodies. Rheumatology (Oxford). 2021;60(3):1148\u201357.","journal-title":"Rheumatology (Oxford)"},{"key":"8606_CR34","doi-asserted-by":"publisher","first-page":"1445852","DOI":"10.3389\/fimmu.2024.1445852","volume":"15","author":"K Tanimura","year":"2024","unstructured":"Tanimura K, Saito S, Tsuda S, et al. Low-dose aspirin and heparin treatment improves pregnancy outcome in recurrent pregnancy loss women with anti-\u03b22-glycoprotein I\/HLA-DR autoantibodies: a prospective, multicenter, observational study. Front Immunol. 2024;15:1445852.","journal-title":"Front Immunol"},{"key":"8606_CR35","doi-asserted-by":"crossref","unstructured":"Huang S, Ninivaggi M, Chayoua W, de Laat B. VWF, Platelets and the Antiphospholipid Syndrome. Int J Mol Sci. 2021;22(8):4200.","DOI":"10.3390\/ijms22084200"},{"key":"8606_CR36","first-page":"CD012852","volume":"5","author":"EN Hamuly\u00e1k","year":"2020","unstructured":"Hamuly\u00e1k EN, Scheres LJ, Marijnen MC, Goddijn M, Middeldorp S. Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss. Cochrane Database Syst Rev. 2020;5:CD012852.","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"8606_CR37","doi-asserted-by":"publisher","first-page":"rkaf005","DOI":"10.1093\/rap\/rkaf005","volume":"9","author":"K Kortright-Maldonado","year":"2025","unstructured":"Kortright-Maldonado K, Reyes-Torres BE, Cabrera-Lopez LS, Rodr\u00edguez-Henr\u00edquez P, Tenorio-Aguirre EK, Mart\u00ednez-S\u00e1nchez FD. Navigating antiphospholipid syndrome: from personalized therapies to cutting-edge research. Rheumatol Adv Pract. 2025;9(1):rkaf005.","journal-title":"Rheumatol Adv Pract"},{"key":"8606_CR38","doi-asserted-by":"publisher","first-page":"109804","DOI":"10.1016\/j.clim.2023.109804","volume":"256","author":"Z Ding","year":"2023","unstructured":"Ding Z, Pan H, Yang Z, Yang C, Shi H. Beyond the classics: the emerging value of anti-phosphatidylserine\/prothrombin antibodies in antiphospholipid syndrome. Clin Immunol. 2023;256:109804.","journal-title":"Clin Immunol"},{"issue":"4","key":"8606_CR39","first-page":"552","volume":"51","author":"H Khogeer","year":"2021","unstructured":"Khogeer H, Altahan S, Alrehaily A, et al. The diagnostic value of new additional antiphospholipid antibodies in antiphospholipid syndrome. Ann Clin Lab Sci. 2021;51(4):552\u20136.","journal-title":"Ann Clin Lab Sci"},{"issue":"1","key":"8606_CR40","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s12969-022-00732-4","volume":"20","author":"SA Mahmud","year":"2022","unstructured":"Mahmud SA, Bullock DR, Correll CK, et al. Non-criteria antiphospholipid antibodies and pediatric rheumatic disease: a case series. Pediatr Rheumatol Online J. 2022;20(1):70.","journal-title":"Pediatr Rheumatol Online J"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12884-025-08606-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-025-08606-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-025-08606-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T15:27:02Z","timestamp":1770391622000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12884-025-08606-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,10]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8606"],"URL":"https:\/\/doi.org\/10.1186\/s12884-025-08606-9","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,10]]},"assertion":[{"value":"8 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the local ethics committee of the Jinshan Branch of Shanghai Sixth People\u2019s Hospital. All experiments were performed in accordance with relevant guidelines and regulations such as the Declaration of Helsinki and the patients signed the informed consent form and agreed to be published.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"139"}}